KELLERMAN DONALD J 4
4 · Zosano Pharma Corp · Filed Jun 7, 2021
Insider Transaction Report
Form 4
KELLERMAN DONALD J
VP, Clinical Dev & Med Affairs
Transactions
- Sale
Common Stock
2021-06-04$0.81/sh−1,709$1,376→ 50,337 total
Footnotes (1)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units of the Issuer.